biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 223 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Mr. Bret Christensen 2025 'den beri şirketle birlikte olan Biote Corp 'in Chief Executive Officer 'ıdır.
BTMD hissesinin fiyat performansı nasıl?
BTMD 'in mevcut fiyatı $2.21 'dir, son işlem günde 0% azalmış etti.
Biote Corp için ana iş temaları veya sektörler nelerdir?
Biote Corp Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Biote Corp 'in piyasa değerlemesi nedir?
Biote Corp 'in mevcut piyasa değerlemesi $86.8M 'dir
Biote Corp al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 7 analist Biote Corp için analist derecelendirmeleri gerçekleştirdi, bunlar 3 güçlü al, 6 al, 2 tut, 0 sat ve 3 güçlü sat içermektedir